Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences

被引：8
作者：
Merckel, L. G. [1 ]
Pomp, J. [1 ]
Hackett, S. L. [1 ]
van Lier, A. L. H. M. W. [1 ]
Dobbelsteen, M. van den [1 ]
Rasing, M. J. A. [1 ]
Hoesein, F. A. A. Mohamed [2 ]
Snoeren, L. M. W. [1 ]
van Es, C. A. [1 ]
van Rossum, P. S. N. [1 ]
Fast, M. F. [1 ]
Verhoeff, J. J. C. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Radiotherapy, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
来源：
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY | 2024年 / 45卷
关键词：
MR-Linac; SBRT; (Ultra) central lung tumour; RADIATION-THERAPY; ADAPTIVE RADIOTHERAPY; GUIDED RADIOTHERAPY; PRECISION; ORGANS; RISK;
D O I：
10.1016/j.ctro.2024.100744
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: MRI-guidance may aid better discrimination between Organs at Risk (OARs) and target volumes in proximity of the mediastinum. We report the first clinical experiences with Stereotactic Body Radiotherapy (SBRT) of (ultra)central lung tumours on a 1.5 T MR-linac. Materials and Methods: Patients with an (ultra)central lung tumour were selected for MR-linac based SBRT treatment. A T2-weighted 3D sequence MRI acquired during free breathing was used for daily plan adaption. Prior to each fraction, contours of Internal Target Volume (ITV) and OARs were deformably propagated and amended by a radiation oncologist. Inter-fractional changes in volumes and coverage of target volumes as well as doses in OARs were evaluated in offline and online treatment plans. Results: Ten patients were treated and completed 60 Gy in 8 or 12 fractions. In total 104 fractions were delivered. The median time in the treatment room was 41 min with a median beam-on time of 8.9 min. No grade >= 3 acute toxicity was observed. In two patients, the ITV significantly decreased during treatment (58 % and 37 %, respectively) due to tumour shrinkage. In the other patients, 81 % of online ITVs were within +/- 15 % of the volume of fraction 1. Comparison with the pre-treatment plan showed that ITV coverage of the online plan was similar in 52 % and improved in 34 % of cases. Adaptation to meet OAR constraints, led to decreased ITV coverage in 14 %. Conclusions: We describe the workflow for MR-guided Radiotherapy and the feasibility of using 1.5 T MR-linac for SBRT of (ultra) central lung tumours.
引用
收藏
页数：6
相关论文
共 32 条
[1]   Magnetic resonance imaging in precision radiation therapy for lung cancer [J].
Bainbridge, Hannah ;
Salem, Ahmed ;
Tijssen, Rob H. N. ;
Dubec, Michael ;
Wetscherek, Andreas ;
Van Es, Corinne ;
Belderbos, Jose ;
Faivre-Finn, Corinne ;
McDonald, Fiona .
TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (06) :689-707
[2]   MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges [J].
Chetty, Indrin J. ;
Doemer, Anthony J. ;
Dolan, Jennifer L. ;
Kim, Joshua P. ;
Cunningham, Justine M. ;
Dragovic, Jadranka ;
Feldman, Aharon ;
Walker, Eleanor M. ;
Elshaikh, Mohamed ;
Adil, Khaled ;
Movsas, Benjamin ;
Parikh, Parag J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05) :950-967
[3]   Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91 [J].
de Jong, Evelyn E. C. ;
Guckenberger, Matthias ;
Andratschke, Nicolaus ;
Dieckmann, Karin ;
Hoogeman, Mischa S. ;
Milder, Maaike ;
Moller, Ditte Sloth ;
Nyeng, Tine Bisballe ;
Tanadini-Lang, Stephanie ;
Lartigau, Eric ;
Lacornerie, Thomas ;
Senan, Suresh ;
Verbakel, Wilko ;
Verellen, Dirk ;
De Kerf, Geert ;
Hurkmans, Coen .
RADIOTHERAPY AND ONCOLOGY, 2020, 142 :217-223
[4]   Organs at risk in lung SBRT [J].
De Rose, F. ;
Franceschini, D. ;
Reggiori, G. ;
Stravato, A. ;
Navarria, P. ;
Ascolese, A. M. ;
Tomatis, S. ;
Mancosu, P. ;
Scorsetti, M. .
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2017, 44 :131-138
[5]   Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver [J].
Dhont, J. ;
Harden, S., V ;
Chee, L. Y. S. ;
Aitken, K. ;
Hanna, G. G. ;
Bertholet, J. .
CLINICAL ONCOLOGY, 2020, 32 (12) :792-804
[6]   Tumor Trailing for Liver SBRT on the MR-Linac [J].
Fast, Martin ;
van de Schoot, Agustinus ;
van de Lindt, Tessa ;
Carbaat, Casper ;
van der Heide, Uulke ;
Sonke, Jan-Jakob .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (02) :468-478
[7]   The future of MRI in radiation therapy: challenges and opportunities for the MR community [J].
Goodburn, Rosie J. ;
Philippens, Marielle E. P. ;
Lefebvre, Thierry L. ;
Khalifa, Aly ;
Bruijnen, Tom ;
Freedman, Joshua N. ;
Waddington, David E. J. ;
Younus, Eyesha ;
Aliotta, Eric ;
Meliado, Gabriele ;
Stanescu, Teo ;
Bano, Wajiha ;
Fatemi-Ardekani, Ali ;
Wetscherek, Andreas ;
Oelfke, Uwe ;
van den Berg, Nico ;
Mason, Ralph P. ;
van Houdt, Petra J. ;
Balter, James M. ;
Gurney-Champion, Oliver J. .
MAGNETIC RESONANCE IN MEDICINE, 2022, 88 (06) :2592-2608
[8]   Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors [J].
Grimbergen, Guus ;
Hackett, Sara L. ;
van Ommen, Fasco ;
van Lier, Astrid L. H. M. W. ;
Borman, Pim T. S. ;
Meijers, Lieke T. C. ;
de Groot-van Breugel, Eline N. ;
de Boer, Johannes C. J. ;
Raaymakers, Bas W. ;
Intven, Martijn P. W. ;
Meijer, Gert J. .
RADIOTHERAPY AND ONCOLOGY, 2023, 189
[9]   Clinical prediction model to characterize pulmonary nodules -: Validation and added value of 18F-fluorodeoxyglucose positron emission tomography [J].
Herder, GJ ;
van Tinteren, H ;
Golding, RP ;
Kostense, PJ ;
Comans, EF ;
Smit, EF ;
Hoekstra, OS .
CHEST, 2005, 128 (04) :2490-2496
[10]   Stereotactic body radiation therapy (SBRT) for early-stage lung cancer [J].
Hiraoka, M. ;
Matsuo, Y. ;
Nagata, Y. .
CANCER RADIOTHERAPIE, 2007, 11 (1-2) :32-35
1234